Additive effects of ezetimibe, evolocumab, and alirocumab on plaque burden and lipid content as assessed by intravascular ultrasound: A PRISMA-compliant meta-analysis

The additive effects of ezetimibe, evolocumab or alirocumab on lipid level, plaque volume, and plaque composition using intravascular ultrasound (IVUS) remain unclear. METHODS: According to the Preferred Reporting Items for Systematic reviews and Meta-Analyses statement, we performed a systematic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Di, Li, Chang, Tu, Yanming, Li, Zhiyong, Zhang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575789/
https://www.ncbi.nlm.nih.gov/pubmed/36254013
http://dx.doi.org/10.1097/MD.0000000000031199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575789/
https://www.ncbi.nlm.nih.gov/pubmed/36254013
http://dx.doi.org/10.1097/MD.0000000000031199

Ejemplares similares